: Healthcare providers and public health officials managing immunocompromised persons with coronavirus disease 2019 (COVID-19) under home isolation.
Limited information is available to characterize the spectrum of clinical illness, transmission efficiency, and the duration of viral shedding for immunocompromised persons with novel coronavirus disease (COVID-19).
Experience from other respiratory viral infections, in particular influenza, suggests that persons with COVID-19 may shed detectable viral material and potentially infectious virus for an extended period of time after recovery.
Where there is concern that immunocompromised persons (e.g., medical treatment with immunosuppressive drugs, bone marrow or solid organ transplant